Health-related quality of life in patients with common variable immunodeficiency switching from intravenous to subcutaneous immunoglobulin therapy
Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency disease (PID) among adults. CVID consists of two phenotypes – one in which infections are the characteristic and another in which impressive inflammatory and/or hematological complications also develop, i...
Main Authors: | Mona Al-Ahmad, Ahmed Maher, Jasmina Nurkic |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2017-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=2;spage=77;epage=82;aulast=Al-Ahmad |
Similar Items
-
Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss
by: Pınar Gür-Çetinkaya, et al.
Published: (2018-06-01) -
A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
by: Kristin Epland, et al.
Published: (2022-09-01) -
Clinical and Immunological Features of Common Variable Immunodeficiency in China
by: Lian-Jun Lin, et al.
Published: (2015-01-01) -
Primary immunodeficiency in adults: total variable immune deficiency clinical manifestations, immunological and genetic defects, treatment
by: Aleksandr Viktorovich Karaulov, et al.
Published: (2011-10-01) -
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
by: Andrea Visentin, et al.
Published: (2022-12-01)